"instanceType","uuid:ID","name","text","id","description","label"
"Objective","2a81c098-e716-460f-8e82-e23d7ab40860","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","Objective_1","Main objective",""
"Objective","657b02b0-1424-4c1b-bd6b-70c651a60c8b","OBJ2","To document the safety profile of the xanomeline TTS.","Objective_2","Safety",""
"Objective","6a5cc702-6d9e-447d-a1d7-29ff3cb4e436","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","Objective_3","Behaviour",""
